Stonepine Capital Management, LLC 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:55 pm Sale | 2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | Stonepine Capital Management, LLC | 0 0.000% | -543,781 (Position Closed) | Filing |
| 2021-02-18 7:48 pm Purchase | 2021-01-27 | 13G | Catalyst Biosciences, Inc. CBIO | Stonepine Capital Management, LLC | 543,781 6.900% | 332,221 (+157.03%) | Filing |
| 2021-02-12 5:00 pm Sale | 2020-12-31 | 13G | Catalyst Biosciences, Inc. CBIO | Stonepine Capital Management, LLC | 211,561 3.800% | -51,920 (-19.71%) | Filing |
| 2020-08-05 4:09 pm Purchase | 2020-03-03 | 13G | Catalyst Biosciences, Inc. CBIO | Stonepine Capital Management, LLC | 263,481 6.000% | 263,481 (New Position) | Filing |
| 2020-03-12 4:58 pm Purchase | 2020-03-03 | 13G | Catalyst Biosciences, Inc. CBIO | Stonepine Capital Management, LLC | 263,481 6.000% | 263,481 (New Position) | Filing |